Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
NF-κB determines localization and features of cell death in epidermis
Cornelia S. Seitz, Rachel A. Freiberg, Kaede Hinata, Paul A. Khavari
Cornelia S. Seitz, Rachel A. Freiberg, Kaede Hinata, Paul A. Khavari
View: Text | PDF
Article

NF-κB determines localization and features of cell death in epidermis

  • Text
  • PDF
Abstract

Specialized forms of physiologic cell death lacking certain characteristic morphologic features of apoptosis occur in terminally differentiating tissues, such as in the outer cell layers of epidermis. In these cell layers, NF-κB translocates from the cytoplasm to the nucleus and induces target gene expression. In light of its potent role in regulating apoptotic cell death in other tissues, NF-κB activation in these cells suggests that this transcription factor regulates cell death during terminal differentiation. Here, we show that NF-κB protects normal epithelial cells from apoptosis induced by both TNFα and Fas, whereas NF-κB blockade enhances susceptibility to death via both pathways. Expression of IκBαM under control of keratin promoter in transgenic mice caused a blockade of NF-κB function in the epidermis and provoked premature spontaneous cell death with apoptotic features. In normal tissue, expression of the known NF-κB–regulated antiapoptotic factors, TRAF1, TRAF2, c-IAP1, and c-IAP2, is most pronounced in outer epidermis. In transgenic mice, NF-κB blockade suppressed this expression, whereas NF-κB activation augmented it, consistent with regulation of cell death by these NF-κB effector proteins. These data identify a new role for NF-κB in preventing premature apoptosis in cells committed to undergoing physiologic cell death and indicate that, in stratified epithelium, such cell death normally proceeds via a distinct pathway that is resistant to NF-κB and its antiapoptotic target effector genes.J. Clin. Invest.105:253–260 (2000).

Authors

Cornelia S. Seitz, Rachel A. Freiberg, Kaede Hinata, Paul A. Khavari

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
Epidermal apoptosis with blockade of NF-κB function in vivo. (a–c) Histo...
Epidermal apoptosis with blockade of NF-κB function in vivo. (a–c) Histology of skin in vivo. (a) Age- and site-matched control versus (b, c) IκBαM[+] mice transgenic for loss of epidermal NF-κB function. Note the presence of apoptotic cell morphologic changes extending down to the lower spinous layers (arrows) and the complete absence of such changes in the control. (d–f) TUNEL assay in vivo. (d) Age- and site-matched control versus (e, f) mice transgenic for loss of epidermal NF-κB function. Note the presence of TUNEL-positive cells in the granular layer extending down into the lower spinous layers in IκBαM[+] mice. (a, b, d, e) Bars = 50 μm, (c, f) bars = 25 μm. Expression of the terminal differentiation marker loricrin is not inhibited by NF-κB blockade in vivo. Skin from (g) keratin promoter–driven IκBαM[+] transgenic mice (NL) (h) and littermate control were immunostained using antibody specific for loricrin. (i) Anti-mouse secondary antibody alone controls for background immunofluorescence. The dermal-epidermal boundary is highlighted by white dots. (g, h) Bars = 40 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts